Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 01 - 24 tags : Application save search
Mustang Bio Provides an Update on its IND Application for MB-207, a Lentiviral Gene Therapy for Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”) in Previously Transplanted Patients
Published: 2022-01-24 (Crawled : 00:00) - biospace.com/
MBIO | $0.365 7.35% 48K
|
Health Technology
|
| O: -5.38%
H: 5.69%
C: 5.69%
FBIO | $1.78 1.71% 74K
|
Health Technology
|
| O: -1.02%
H: 7.93%
C: 6.95%
mb-207 treatment application gene therapy therapy
Huntington Beach Desalination Facility Coastal Development Permit Application Deemed Complete
Published: 2022-01-24 (Crawled : 19:00) - prnewswire.com
FNCTF | News | $11.16 130
|
Communications
| Email alert
Add to watchlist
huntington application desalination
TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-100 for the Treatment of Hematologic Malignancies
Published: 2022-01-24 (Crawled : 13:00) - biospace.com/
TCRX | News 3 d | $7.235 1.62% 140K
|
Professional, Scientific, and T...
|
| O: -1.26%
H: 0.0%
C: -6.82%
tsc-100 new drug treatment fda ema clearance application drug therapeutics fda clearance 100 scan
SQZ Biotechnologies Announces FDA Clearance of Investigational New Drug (IND) Application for SQZ-eAPC-HPV, a Novel mRNA-based Cell Therapy for the Treatment of HPV16 Positive Solid Tumors
Published: 2022-01-24 (Crawled : 12:00) - biospace.com/
SQZ | $0.435 0.0% 30M
|
Health Technology
|
| O: -3.62%
H: 7.66%
C: 6.27%
hpv16 new drug treatment fda clearance solid tumors application hpv drug cel fda clearance positive therapy biotech iot
Worldwide Transparent Conductive Films Industry to 2027 - Potential Demand for Photovoltaic Application and Displays Presents Opportunities
Published: 2022-01-24 (Crawled : 12:00) - prnewswire.com
KODK | $4.67 0.22% 250K
|
Electronic Technology
|
| O: -6.63%
H: 2.11%
C: 2.11%
ema application potential photo photovoltaic
Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs
Published: 2022-01-24 (Crawled : 08:00) - biospace.com/
RLFTF | $1.45 1.3K
|
n/a
|
| O: -1.54%
H: 4.17%
C: -0.26%
application patent research therapeutics
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
PALI | $6.29 27.59% 22M
|
Manufacturing
MCRB | $0.7902 26.51% 6.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.